<DOC>
	<DOCNO>NCT00773175</DOCNO>
	<brief_summary>Randomized ( 1:1 ratio ) study SC versus IV fluid rehydration mildly moderately dehydrated pediatric patient .</brief_summary>
	<brief_title>Subcutaneous Rehydration Compared Intravenous Rehydration</brief_title>
	<detailed_description>This prospective , randomize ( 1:1 ratio ) , open-label , parallel group , multicenter , multi-national , study SC versus IV fluid rehydration mildly moderately dehydrated pediatric patient treat Emergency Department ( ED ) , inpatient pediatric unit , and/or outpatient urgent care facility . It expect 186 patient , order achieve 148 evaluable patient , randomize 1:1 ratio receive isotonic fluid rehydration either SC administration hylenex ( 150 Units ) IV without hylenex .</detailed_description>
	<mesh_term>Dehydration</mesh_term>
	<criteria>Children either gender one month &lt; 3 year age . Patients mild moderate dehydration Healthy child except underlie etiology dehydration Predehydration body weight â‰¥ 5th percentile age Parents legal guardian ( ) available provide inform consent . Severe dehydration Shock lifethreatening situation ( life expectancy &lt; 10 day ) . Requirement IV access indication treatment dehydration . Indwelling IV catheter , except one intend collection clinical laboratory specimen . Any condition preclude SC infusion infusion site evaluation Any reason ( prior study enrollment ) hospital admission extend stay ED dehydration . Known hypersensitivity hyaluronidase hylenex . Known hyponatremia ( &lt; 130 mEg/L ) hypernatremia ( &gt; 155 mEq/L ) . Known hypokalemia ( &lt; 3.0 mEq/L ) . Any medical condition likely interfere patient 's ability fully complete protocolspecified intervention , ability undergo protocolspecified assessment , likely prolong patient 's need medical attention beyond require treatment dehydration . Participation investigational drug device study within 30 day prior enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>pediatric</keyword>
	<keyword>hylenex</keyword>
	<keyword>subcutaneous infusion</keyword>
	<keyword>hyaluronidase</keyword>
	<keyword>rHuPH20</keyword>
	<keyword>recombinant human hyaluronidase</keyword>
</DOC>